15-40281640-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001190479.3(ANKRD63):c.947C>T(p.Pro316Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000813 in 1,525,108 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001190479.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD63 | NM_001190479.3 | c.947C>T | p.Pro316Leu | missense_variant | 1/1 | ENST00000434396.2 | NP_001177408.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD63 | ENST00000434396.2 | c.947C>T | p.Pro316Leu | missense_variant | 1/1 | 6 | NM_001190479.3 | ENSP00000399547.1 | ||
PLCB2 | ENST00000560009.1 | n.394+2799C>T | intron_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152204Hom.: 2 Cov.: 34
GnomAD3 exomes AF: 0.000222 AC: 27AN: 121762Hom.: 0 AF XY: 0.000284 AC XY: 19AN XY: 66936
GnomAD4 exome AF: 0.0000830 AC: 114AN: 1372786Hom.: 3 Cov.: 35 AF XY: 0.000117 AC XY: 79AN XY: 676356
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152322Hom.: 2 Cov.: 34 AF XY: 0.0000940 AC XY: 7AN XY: 74496
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 08, 2022 | The c.947C>T (p.P316L) alteration is located in exon 1 (coding exon 1) of the ANKRD63 gene. This alteration results from a C to T substitution at nucleotide position 947, causing the proline (P) at amino acid position 316 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at